- Posted Tuesday March 3, 2020
Women’s cancers research at TGen lifted up by latest fashions March 6 at Neiman Marcus Scottsdale
New luxury wing of Scottsdale Fashion Square to serve as backdrop to Runway for Research fashion show
SCOTTSDALE, Ariz. — March 3, 2020 — Celebrating the change of seasons in Arizona, a new fashion show — Runway for Research — will premier March 6 at Neiman Marcus Scottsdale, helping kickoff the opening of the recently expanded and upgraded luxury wing of Scottsdale Fashion Square, while also benefiting women’s cancers research at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Runway for Research, in partnership with Neiman Marcus and Scottsdale Fashion Square, will feature dozens of models showcasing the latest spring fashions, using the new luxury wing of the mall as the event’s runway.
“Scottsdale Fashion Square is a vibrant and exciting experience, especially the new luxury wing, anchored by Neiman Marcus. We’re happy and excited to present TGen’s Runway for Research in this beautiful space,” said event Co-chair Vicki Vaughn.
Complimentary valet parking will be available at the east entrance to Neiman Marcus, facing Goldwater Boulevard. The two-hour event, featuring champagne and hors d'oeuvres, starts at 8:30 a.m. March 6.
“We are so very proud to host the inaugural Runway for Research, supporting the important life-saving treatment for women with cancer developed by TGen,” said Timothy Braun, Vice President and General Manager of Neiman Marcus. “This is an exceptional event and fundraising effort, and we are happy to partner for the first time with TGen for the benefit of women in our community.”
Tickets are $1,000 for the VIP Experience (which includes two premium seats and a VIP-only raffle) or $150 per Fashionista seat. Runway for Research already has raised more than $100,000.
To register, please visit: https://www.tgen.org/giving/events/runway-for-research/
“We look forward to a lively morning that will showcase Neiman Marcus’s new fashions, but also will make a lasting impact on the lives of women with cancer through TGen’s life-changing, patient-focused research,” said event Co-chair Robyn DeBell.
Runway for Research will feature models showing off new spring fashion collections in the mall’s new luxury wing, which recently underwent a more than $140 million renovation and expansion.
“This is an incredible opportunity to partner with Neiman Marcus and Fashion Square, surrounding the opening of the new luxury wing,” said Erin Massey, Chief Development Officer at TGen, and Vice President of Philanthropy at City of Hope.
“We are very grateful to Vicki Vaughn and Robyn DeBell for chairing Runway for Research, and for making this inaugural event a success,” Massey said. “We look forward to delivering a morning of fashion, friendship and fun that benefits the thousands of patients who need our help today.”
For more details, please contact Jennie Patel, Events Manager for the TGen Foundation, at: [email protected] or 602-343-8725.
Major sponsors of Runway for Research include the Pakis Family Foundation, Mercedes-Benz of Scottsdale, Charlene Berge-Blum, T.W. Lewis Foundation, Gretchen Ventura, Charles Schwab, Nita Francis, and The Sauce Foundation.
# # #
About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: www.cityofhope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
TGen Senior Science Writer